|
[1]
|
Carney, E.F. (2020) The Impact of Chronic Kidney Disease on Global Health. Nature Reviews Nephrology, 16, 251. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Hu, J., Ke, R., Teixeira, W., et al. (2023) Global, Regional, and National Burden of CKD due to Glomerulonephritis from 1990 to 2019: A Systematic Analysis from the Global Burden of Disease Study 2019. Clinical Journal of the American Society of Nephrology, 18, 60-71. [Google Scholar] [CrossRef]
|
|
[3]
|
GBD Chronic Kidney Disease Collaboration (2020) Global, Regional, and National Burden of Chronic Kidney Disease, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017. The Lancet, 395, 709-733.
|
|
[4]
|
Chinese Preventive Medicine Association for Kidney Disease (2023) Guidelines for the Early Evaluation and Management of Chronic Kidney Disease in China. Chinese Journal of In-ternal Medicine, 62, 902-930.
|
|
[5]
|
Bertoldo, F., Cianferotti, L., Di Monaco, M., et al. (2022) Definition, Assessment, and Management of Vitamin D Inadequacy: Suggestions, Recommendations, and Warnings from the Italian Society for Osteoporosis, Mineral Metabolism and Bone Diseases (SIOMMMS). Nutrients, 14, Article 4148. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Lee, S., Chung, H.J., Jung, S., et al. (2023) 24, 25-Dihydroxy Vitamin D and Vitamin D Metabolite Ratio as Biomarkers of Vitamin D in Chronic Kidney Disease. Nutrients, 15, Article 578. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Wimalawansa, S.J. (2023) Infections and Autoimmunity—The Immune System and Vitamin D: A Systematic Review. Nutrients, 15, Article 3842. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Romano, F., Serpico, D., Cantelli, M., et al. (2023) Osteoporosis and Dermatoporosis: A Review on the Role of Vitamin D. Frontiers in Endocrinology, 14, Article 1231580. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Ikizler, T.A., Burrowes, J.D., Byham-Gray, L.D., et al. (2020) KDOQI Clinical Practice Guideline for Nutrition in CKD: 2020 Update. American Journal of Kidney Diseases, 76, S1-S107. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Franca Gois, P.H., Wolley, M., Ranganathan, D. and Seguro, A.C. (2018) Vitamin D Deficiency in Chronic Kidney Disease: Recent Evidence and Controversies. Internation-al Journal of Environmental Research and Public Health, 15, Article 1773. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Bhan, I., Burnett-Bowie, S.A., Ye, J., et al. (2010) Clinical Measures Identify Vitamin D Deficiency in Dialysis. Clinical Journal of the American Society of Nephrology, 5, 460-467. [Google Scholar] [CrossRef]
|
|
[12]
|
Alfieri, C., Ruzhytska, O., Vettoretti, S., et al. (2019) Native Hypo-vitaminosis D in CKD Patients: From Experimental Evidence to Clinical Practice. Nutrients, 11, Article 1918. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Yang, S., Li, A., Wang, J., et al. (2018) Vitamin D Receptor: A Novel Therapeutic Target for Kidney Diseases. Current Medicinal Chemistry, 25, 3256-3271. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Gembillo, G., Siligato, R., Amatruda, M., et al. (2021) Vitamin D and Glomerulonephritis. Medicina, 57, Article 186. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Xu, J., Yang, J., Chen, J., et al. (2017) Vitamin D Alleviates Lip-opolysaccharide-Induced Acute Lung Injury via Regulation of the Renin-Angiotensin System. Molecular Medicine Re-ports, 16, 7432-7438. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Zaheer, S., Taquechel, K., Brown, J.M., et al. (2018) A Randomized Intervention Study to Evaluate the Effect of Calcitriol Therapy on the Renin-Angiotensin System in Diabetes. Journal of the Renin-Angiotensin-Aldosterone System, 19. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Grübler, M.R., Gaksch, M., Kienreich, K., et al. (2016) Effects of Vitamin D Supplementation on Plasma Aldosterone and Renin—A Randomized Placebo-Controlled Trial. The Journal of Clinical Hypertension, 18, 608-613. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Goncalves, L.E.D., Andrade-Silva, M., Basso, P.J. and Câmara, N.O.S. (2023) Vitamin D and Chronic Kidney Disease: Insights on Lipid Metabolism of Tubular Epithelial Cell and Macro-phages in Tubulointerstitial Fibrosis. Frontiers in Physiology, 14, Article 1145233. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Zhang, Z.H., Luo, B., Xu, S., et al. (2021) Long-Term Vitamin D Deficiency Promotes Renal Fibrosis and Functional Impairment in Middle-Aged Male Mice. British Journal of Nutrition, 125, 841-850. [Google Scholar] [CrossRef]
|
|
[20]
|
Jiang, W.J., Xu, C.T., Du, C.L., et al. (2022) Tubular Epithelial Cell-to-Macrophage Communication Forms a Negative Feedback Loop via Extracellular Vesicle Transfer to Promote Re-nal Inflammation and Apoptosis in Diabetic Nephropathy. Theranostics, 12, 324-339. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Moslemi, E., Musazadeh, V., Kavyani, Z., et al. (2022) Efficacy of Vita-min D Supplementation as an Adjunct Therapy for Improving Inflammatory and Oxidative Stress Biomarkers: An Um-brella Meta-Analysis. Pharmacological Research, 186, Article ID: 106484. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
De Braganca, A.C., Canale, D., Goncalves, J.G., et al. (2018) Vitamin D Deficiency Aggravates the Renal Features of Moderate Chronic Kidney Disease in 5/6 Nephrectomized Rats. Frontiers in Medicine, 5, Article 406289. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Mansouri, L., Lundwall, K., Moshfegh, A., et al. (2017) Vitamin D Receptor Activation Reduces Inflammatory Cytokines and Plasma MicroRNAs in Moderate Chronic Kidney Disease—A Randomized Trial. BMC Nephrology, 18, Article No. 161. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
de Oliveira E Silva Ullmann, T., Ramalho, B.J., Laurindo, L.F., et al. (2023) Effects of Vitamin D Supplementation in Dia-betic Kidney Disease: An Systematic Review. Journal of Renal Nutrition, 33, 618-628. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Shi, L., Xiao, C., Zhang, Y., et al. (2022) Vitamin D/Vitamin D Re-ceptor/Atg16L1 Axis Maintains Podocyte Autophagy and Survival in Diabetic Kidney Disease. Renal Failure, 44, 694-705. [Google Scholar] [CrossRef]
|
|
[26]
|
Garsen, M., Sonneveld, R., Rops, A.L., et al. (2015) Vita-min D Attenuates Proteinuria by Inhibition of Heparanase Expression in the Podocyte. The Journal of Pathology, 237, 472-481. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Wang, H., Wang, J., Qu, H., et al. (2016) In Vitro and in Vivo In-hibition of mTOR by 1,25-Dihydroxyvitamin D3 to Improve Early Diabetic Nephropathy via the DDIT4/TSC2/mTOR Pathway. Endocrine, 54, 348-359. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Zhao, D., Zhang, C.J., Yang, R., et al. (2017) Effect of 1,25(OH)2D3 on the Proliferation of Human Mesangial Cells and Their Expression of Ki67. Genetics and Molecular Re-search, 16, gmr16029191. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Fu, H., Gu, Y.H., Tan, J., Yang, Y.N. and Wang, G.H. (2022) CircACTR2 in Macrophages Promotes Renal Fibrosis by Activating Macrophage Inflammation and Epitheli-al-Mesenchymal Transition of Renal Tubular Epithelial Cells. Cellular and Molecular Life Sciences, 79, Article No. 253. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Liu, K.H., Fu, J., Zhou, N., et al. (2019) 1,25-Dihydroxyvitamin D3 Prevents Epithelial-Mesenchymal Transition of HMrSV5 Human Peritoneal Mesothelial Cells by Inhibiting Histone Deacetylase 3 (HDAC3) and Increasing Vitamin D Receptor (VDR) Expression through the Wnt/β-Catenin Signaling Pathway. Medical Science Monitor, 8, 5892-5902. [Google Scholar] [CrossRef]
|
|
[31]
|
Yang, L., Wu, L., Zhang, X., et al. (2017) 1, 25(OH)2D3/VDR At-tenuates High Glucose-Induced Epithelial-Mesenchymal Transition in Human Peritoneal Mesothelial Cells via the TGFβ/Smad3 Pathway. Molecular Medicine Reports, 15, 2273-2279. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Naveh-Many, T. and Volovelsky, O. (2020) Parathyroid Cell Prolif-eration in Secondary Hyperparathyroidism of Chronic Kidney Disease. International Journal of Molecular Sciences, 21, Article 4332. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Cipriani, C., Pepe, J., Colangelo, L., et al. (2018) Vitamin D and Sec-ondary Hyperparathyroid States. Frontiers of Hormone Research, 50, 138-148. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Charoenngam, N., Shirvani, A. and Holick, M.F. (2019) Vitamin D for Skeletal and Nonskeletal Health: What We Should Know. Journal of Clinical Orthopaedics and Trauma, 10, 1082-1093. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
Gasperini, B., Visconti, V.V., Ciccacci, C., et al. (2023) Role of the Vitamin D Receptor (VDR) in the Pathogenesis of Osteoporosis: A Genetic, Epigenetic and Molecular Pilot Study. Genes, 14, Article 542. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
Macdonald, H.M., Reid, I.R., Gamble, G.D., et al. (2018) 25-Hydroxyvitamin D Threshold for the Effects of Vitamin D Supplements on Bone Density: Secondary Analysis of a Randomized Controlled Trial. Journal of Bone and Mineral Research, 33, 1464-1469. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
Renke, G., Starling-Soares, B., Baesso, T., et al. (2023) Effects of Vitamin D on Cardiovascular Risk and Oxidative Stress. Nutrients, 15, Article 769. [Google Scholar] [CrossRef] [PubMed]
|
|
[38]
|
Jensen, N.S., Wehland, M., Wise, P.M. and Grimm, D. (2023) Latest Knowledge on the Role of Vitamin D in Hypertension. International Journal of Molecular Sciences, 24, Article 4679. [Google Scholar] [CrossRef] [PubMed]
|
|
[39]
|
Wojtasinska, A., Frak, W., Lisinska, W., et al. (2023) Novel Insights into the Molecular Mechanisms of Atherosclerosis. International Journal of Molecular Sciences, 24, Article 13434. [Google Scholar] [CrossRef] [PubMed]
|
|
[40]
|
Hamza, F.N., Daher, S., Fakhoury, H.M.A., et al. (2023) Immuno-modulatory Properties of Vitamin D in the Intestinal and Respiratory Systems. Nutrients, 15, Article 1696. [Google Scholar] [CrossRef] [PubMed]
|
|
[41]
|
Asdie, R.H., Mulya, D.P. and Nainggolan, M. (2023) Assessment of 28-Day Survival of Patients with Sepsis Based on Vitamin D Status: A Hospital-Based Prospective Cohort Study in In-donesia. The Pan African Medical Journal, 45, Article 76. [Google Scholar] [CrossRef] [PubMed]
|
|
[42]
|
Chauss, D., Freiwald, T., McGregor, R., et al. (2022) Auto-crine Vitamin D Signaling Switches off Pro-Inflammatory Programs of TH1 Cells. Nature Immunology, 23, 62-74. [Google Scholar] [CrossRef] [PubMed]
|
|
[43]
|
Li, M., Xu, J., Wan, Q., et al. (2021) Relationship between Se-rum Vitamin D3 Concentration and Anaemia in Patients with Chronic Kidney Disease in China. Journal of International Medical Research, 49. [Google Scholar] [CrossRef] [PubMed]
|
|
[44]
|
Ahmad, S., Ullah, H., Khan, M.I., et al. (2023) Effect of Vitamin D Supplementation on the Hemoglobin Level in Chronic Kidney Disease Patients on Hemodialysis: A Systematic Review and Meta-Analysis. Cureus, 15, e40843. [Google Scholar] [CrossRef] [PubMed]
|
|
[45]
|
Pistis, K.D., Westerberg, P.A., Qureshi, A.R., et al. (2023) The Effect of High-Dose Vitamin D Supplementation on Hepcidin-25 and Erythropoiesis in Patients with Chronic Kidney Disease. BMC Nephrology, 24, Article No. 20. [Google Scholar] [CrossRef] [PubMed]
|
|
[46]
|
Joksimovic Jovic, J., Antic, S., Nikolic, T., et al. (2022) Eryth-ropoietin Resistance Development in Hemodialysis Patients: The Role of Oxidative Stress. Oxidative Medicine and Cel-lular Longevity, 2022, Article ID: 9598211. [Google Scholar] [CrossRef] [PubMed]
|